In this case, the pill, called VXA-G1.1-NN, has been designed to deliver a harmless viral vector carrying a norovirus protein ...

Scientists at Cornell University have developed a new type of vaccine that may provide stronger and longer-lasting protection ...

To maintain vaccine efficacy, WHO regularly updates influenza vaccine strains based on global epidemiological, virological, ...

As viral vaccines are increasingly used to meet global health needs, the pharmaceutical industry is manufacturing larger ...

If the FDA and CDC sit on their hands, next season the flu shot will be a lot more expensive, if you can find it at all. That ...

Scientists can deliver genetic material into the body’s cells, turning them into vaccine factories and skipping time-consuming steps such as manufacturing viral proteins or growing the whole ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

Influenza A and B patients had similar death rates by 90 days (13.4% vs 8.7%, respectively) and proportions of radiologic ...

The U.S. can’t afford another high-ranking health official who is opposed to vaccines.